Public Companies

We have decades of experience representing formerly venture-backed life sciences and technology companies throughout their lives as public companies, bringing extensive industry knowledge and strategic insights to the legal and business advice we provide.

We are strategic advisors to our clients on market dynamics and execution risks and opportunities, and our focus on the innovation economy means we keep our finger on the pulse of the latest terms and trends for securities offerings by our clients. We help our clients anticipate roadblocks and prevent surprises by highlighting regulatory developments, evolving trends and proposed amendments, providing real-time insights to our clients on the changing rules and priorities of the SEC, stock exchanges, proxy advisors, institutional and strategic investors and other key market participants.

Learn More

Public Companies

Trusted Advisors on the Road Ahead

Formerly venture-backed companies are a different kind of public company. We understand that and keep you in the driver's seat.

Reporting & Governance | Acquisitions | Capital Markets

The reporting and governance obligations that come with being a public company can be challenging to keep up with, even for mature public companies. We help newly public technology and life sciences companies adjust to the cadence of public company life, drafting and updating quarterly and annual periodic reports, preparing for proxy season and the annual meeting, responding to events that trigger Form 8-K filings and keeping them up-to-date on the ever-changing regulatory environment. We continue to support more mature public companies with their reporting obligations, bringing our detailed market knowledge for similarly situated companies in the tech and life sciences industries.

Services

Let's Connect

Reporting & Governance | Acquisitions | Capital Markets

If your company’s strategy involves plans to supplement organic growth with acquisitions or other strategic combinations, our team can help ensure you run these buy-side transactions efficiently and cost-effectively. We leverage our deep expertise and market knowledge in technology and life sciences M&A on both the buy-side and sell-side to guide acquirers to achieving optimal outcomes and successful integrations of acquired companies time and again.

Services

Reporting & Governance | Acquisitions | Capital Markets

From follow-on offerings and at-the-market offerings, to Rule 144A convertible notes offerings and private placements of public equity (PIPEs), to secondary offerings and other offering structures, our public company clients pursue a wide variety of capital raising structures. We work seamlessly with underwriters, initial purchasers, strategic investors, auditors, the SEC, stock exchanges and other market participants to support those capital raising priorities.

Services

Our Focus

Related Services

We support our public company clients in the full range of matters – from follow-on offerings and private placements of public equity (PIPEs), to complex executive compensation issues and buy-side M&A, to corporate governance and complex strategic and commercial transactions.